Undervalued Stocks Based On Cash Flows

Results

699

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

699 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
TE
€36.142.8%3.4%€6.3b€44.2418.313.8%2.8%Energy
QTCOM
€24.24-12.6%-57.0%€615.5m€28.5022.623.6%n/aSoftware
NCC B
SEK 192.206.2%-0.2%SEK 18.8bSEK 220.00204.348.7%4.7%Capital Goods
CBHB
RM 0.687.1%195.7%RM 1.3bRM 0.7121.19.6%0.4%Capital Goods
IDX
AU$2.070%-8.8%AU$771.1mAU$3.1455.032.6%3.5%Healthcare
VGL
NZ$2.245.2%-34.9%NZ$536.0mNZ$3.33282.140.2%0%Software
300118
CN¥13.594.1%51.0%CN¥15.2bCN¥23.251.2107.5%0%Semiconductors
BSGR
€5.850%40.6%€492.4m€5.9615.227.7%3.2%Retail
TMK
RM 2.3614.0%108.8%RM 2.4bRM 2.0722.120.4%2.4%Materials
TINS
Rp3,480.0019.6%201.3%Rp25.9tRp4,500.009.619.6%1.8%Materials
002997
CN¥29.977.4%-15.1%CN¥6.3bCN¥38.5015.628.6%1.5%Capital Goods
MRK
US$114.90-3.9%41.9%US$294.0bUS$129.7431.821.2%3.0%Pharmaceuticals & Biotech
TSTL
UK£3.933.3%5.5%UK£188.3mUK£4.7224.014.6%3.6%Healthcare
STYLEBAAZA
₹332.901.1%30.0%₹24.8b₹485.0053.049.9%n/aRetail
BONEX
SEK 219.80-3.9%-20.1%SEK 14.5bSEK 373.8378.233.8%n/aPharmaceuticals & Biotech
A394800
₩7,040.001.3%-11.8%₩224.0bn/a19.1135.6%n/aPharmaceuticals & Biotech
PCR
zł66.20-2.6%-4.7%zł1.3bzł82.4121.820.4%7.6%Materials
ASUR B
Mex$516.376.4%-12.2%Mex$148.0bMex$663.7915.813.1%15.5%Transportation
8046
NT$860.003.5%681.8%NT$555.7bNT$897.45182.359.5%0.2%Tech
ABBV
US$221.59-0.7%16.1%US$402.4bUS$253.55108.925.4%3.1%Pharmaceuticals & Biotech
SDIP B
SEK 254.803.3%18.1%SEK 9.7bSEK 290.201.958.6%n/aCommercial Services
CINT
SEK 5.75-0.3%-21.0%SEK 2.0bSEK 6.351.3113.5%n/aSoftware
3526
NT$320.00-13.0%44.8%NT$20.9bNT$415.0018.231.0%5.3%Tech
VUL
UK£2.670.4%n/aUK£72.8mUK£3.237.579.1%n/aConsumer Retailing
Page 1 of 20